Mohammed Ghazwani
Overview
Explore the profile of Mohammed Ghazwani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
410
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghazwani M, Hani U
Sci Rep
. 2025 Feb;
15(1):6121.
PMID: 39972150
This study investigates the characteristics of cobalt ferrite nanofluids, focusing on their structural, thermal, electrical conductivity, and viscosity properties. The motivation behind this research lies in the potential applications of...
2.
Hani U, Choudhary V, Ghazwani M, Alghazwani Y, Osmani R, Kulkarni G, et al.
Pharmaceutics
. 2025 Jan;
16(12.
PMID: 39771506
Cancer, the most common condition worldwide, ranks second in terms of the number of human deaths, surpassing cardiovascular diseases. Uncontrolled cell multiplication and resistance to cell death are the traditional...
3.
Alghazwani Y, Ghazwani M, Talath S, Wali A, Sridhar S, Fatima F, et al.
Sci Rep
. 2024 Dec;
14(1):30191.
PMID: 39633018
In the present study, the solubility of sulfasalazine in carbon dioxide was investigated at temperatures ranging from 313 K to 343 K and pressures ranging from 12 to 30 MPa....
4.
Shimu S, Rathinavel T, Ghazwani M, Hani U, Khalekuzzaman M, Islam M, et al.
J Biomol Struct Dyn
. 2024 Dec;
:1-21.
PMID: 39628125
Although in the last three decades pharmaceutical industries invented good number of new drugs, resistance to antimicrobials is still prevailing due to the remarkable genetic plasticity of the microbes and...
5.
Goli V, Tatineni S, Hani U, Ghazwani M, Talath S, Sridhar S, et al.
Pharmaceuticals (Basel)
. 2024 Apr;
17(4).
PMID: 38675426
Cerebral malaria (CM), a severe neurological pathology caused by infection, poses a significant global health threat and has a high mortality rate. Conventional therapeutics cannot cross the blood-brain barrier (BBB)...
6.
Alkanad M, Hani U, V A, Ghazwani M, Haider N, Osmani R, et al.
Biofactors
. 2024 Jan;
50(4):634-673.
PMID: 38169069
With the rising prevalence of diabetes and its association with cognitive impairment, interest in the use of dietary alkaloids and other natural products has grown significantly. Understanding how these compounds...
7.
Madhusudhan S, Gupta N, Rahamathulla M, Chidambaram S, Osmani R, Ghazwani M, et al.
Pharmaceutics
. 2023 Oct;
15(10).
PMID: 37896180
Diabetic retinopathy (DR) is a microvascular complication associated with vascular endothelial growth factor (VEGF) overexpression. Therapeutic delivery to the retina is a challenging phenomenon due to ocular biological barriers. Sorafenib...
8.
Ghazwani M, Hani U, Alqarni M, Alam A
Gels
. 2023 Jul;
9(7).
PMID: 37504429
This work aimed to overcome the disadvantages of the oral administration of beta-caryophyllene and boost efficiency by developing a nanostructured lipid carrier for topical administration of the drug in skin...
9.
Ghazwani M, Alqarni M, Hani U, Alam A
Int J Mol Sci
. 2023 Jun;
24(12).
PMID: 37373129
In this study, elastic nanovesicles, constructed of phospholipids optimized by Quality by Design (QbD), release 6-gingerol (6-G), a natural chemical that may alleviate osteoporosis and musculoskeletal-related pain. A 6-gingerol-loaded transfersome...
10.
Ghazwani M, Vasudevan R, Kandasamy G, Manusri N, Devanandan P, Puvvada R, et al.
Gels
. 2023 Jun;
9(6).
PMID: 37367128
The purpose of the present work was to develop nanoemulsion-based formulations of mirtazapine for intranasal delivery using a spray actuator to target the brain for treating depression. Research on the...